PAA 2.33% 21.0¢ pharmaust limited

Ann: MND Trial Completes Enrolment of Cohort 2, page-105

  1. 11,861 Posts.
    lightbulb Created with Sketch. 6014
    100% agree Cainy, The Company has certainly lifted the content of announcements , specifically a Commercial Value attached to Positive Trial Data but a comprehensive strategy surrounding all releases is required...

    Bella is the first Video presentation that PAA has created in years.

    ASX announcements are the Bare Regulatory Legal Requirement ,, Editorial and Interviews are what stimulate interest from NON SH..
    Volume is the indicator of awareness....

    When PAA make an ASX announcement it needs to be followed up with Interviews from the CEO, CSO etc .... just emulate the other successful Bio's.

    The next MND results should be Heralded and then evangelised by the CEO.... gaining Value for SH....

    Don't Tell the Story ,,,SELL the Story.... done well it could easily put the Oppies in the money
    Last edited by NZ Trader: 27/04/23
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.